According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological...

According to a newly published market research report by 24LifeSciences, global Hepatocellular Carcinoma Drugs market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Hepatocellular Carcinoma (HCC), the most common primary liver cancer accounting for 90% of...

The global Keytruda Market was valued at USD 31.4 billion in 2025 and is projected to grow from USD 32.7 billion in 2026 to USD 25.0 billion by 2033, registering a CAGR of -3.8% from 2026 to 2033. While Keytruda (pembrolizumab) remains one of the most successful immunotherapy drugs globally, the market is expected to face headwinds over the forecast period due to patent expiration,...

According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...

According to a newly published market research report by 24LifeSciences, global apoptosis stimulant market was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.65 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period 2025–2030. Apoptosis, or programmed cell death, is a fundamental biological process responsible for...

According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...

According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...

" According to the latest report published by Data Bridge Market Research, the Cancer Biological Therapy Market The global cancer biological therapy market size was valued at USD 133.32 billion in 2025 and is expected to reach USD 246.76 billion by 2033, at a CAGR of 8.00% during the forecast period. The supreme Cancer Biological Therapy Market research report has been built by...

" According to the latest report published by Data Bridge Market Research, the Cancer Monoclonal Antibodies Market The global cancer monoclonal antibodies market size was valued at USD 53.33 billion in 2023 and is expected to reach USD 133.45 billion by 2031, at a CAGR of 14.00% during the forecast period. The world-class Cancer Monoclonal Antibodies Market report analyses some of the...

The anti-PD-1 antibody industry is experiencing significant momentum as immunotherapy continues to transform cancer treatment approaches worldwide. Growing investments in oncology research, expanding clinical applications, and increasing awareness of immune checkpoint inhibitors are creating new opportunities across healthcare systems. The Global Anti-PD-1 Antibody Market Future Trends reflect...